On the public citation graph

Pt-Mal-LHRH, a Newly Synthesized Compound Attenuating Breast Cancer Tumor Growth and Metastasis by Targeting Overexpression of the LHRH Receptor

https://doi.org/10.1021/acs.bioconjchem.6b00610

0 signed · 80 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/0471142735.im2002s39openalex-snapshot

Mouse 4T1 Breast Tumor Model

inferredcites →https://doi.org/10.1002/ijc.26132openalex-snapshot

[DLys 6 ]‐luteinizing hormone releasing hormone–curcumin conjugate inhibits pancreatic cancer cell growth in vitro and in vivo

inferredcites →https://doi.org/10.1002/jcla.1860030302openalex-snapshot

Characteristics and distribution of receptors for [d‐trp6]‐ luteinizing hormone‐releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer

inferredcites →https://doi.org/10.1007/978-0-387-74911-2_32openalex-snapshot

LHRH Receptor Targeted Therapy for Breast Cancer

inferredcites →https://doi.org/10.1016/0020-711x(94)90072-8openalex-snapshot

A comparison of in vitro platinum-DNA adduct formation between carboplatin and cisplatin

inferredcites →https://doi.org/10.1016/j.actbio.2015.02.022openalex-snapshot

Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis

inferredcites →https://doi.org/10.1016/j.apsb.2011.08.001openalex-snapshot

Enzyme-mediated hydrolytic activation of prodrugs

inferredcites →https://doi.org/10.1016/j.carres.2011.08.024openalex-snapshot

Synthesis and hydrolysis studies of novel glyco-functionalized platinum complexes

inferredcites →https://doi.org/10.1016/j.ejca.2003.07.001openalex-snapshot

Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer–doxorubicin conjugates to human colon cancer cells

inferredcites →https://doi.org/10.1016/j.ijpharm.2012.04.033openalex-snapshot

The in vivo antitumor activity of LHRH targeted methotrexate–human serum albumin nanoparticles in 4T1 tumor-bearing Balb/c mice

inferredcites →https://doi.org/10.1016/j.mce.2005.12.056openalex-snapshot

Destruction of breast cancers and their metastases by lytic peptide conjugates in vitro and in vivo

inferredcites →https://doi.org/10.1016/j.mce.2006.06.017openalex-snapshot

Conjugates of lytic peptides and LHRH or βCG target and cause necrosis of prostate cancers and metastases

inferredcites →https://doi.org/10.1016/s0168-3659(01)00538-7openalex-snapshot

Lectin-mediated drug delivery: influence of mucin on cytoadhesion of plant lectins in vitro

inferredcites →https://doi.org/10.1016/s0960-894x(01)00623-0openalex-snapshot

Unprecedented sugar-dependent in vivo antitumor activity of carbohydrate-pendant cis-diamminedichloroplatinum(II) complexes

inferredcites →https://doi.org/10.1016/s1043-2760(97)00155-0openalex-snapshot

Growth-Inhibitory Actions of Analogues of Luteinizing Hormone Releasing Hormone on Tumor Cells

inferredcites →https://doi.org/10.1021/acs.chemrev.5b00597openalex-snapshot

The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs

inferredcites →https://doi.org/10.1021/bc025642lopenalex-snapshot

Folate-Targeted PEG as a Potential Carrier for Carboplatin Analogs. Synthesis and in Vitro Studies

inferredcites →https://doi.org/10.1021/bc900065ropenalex-snapshot

Peptide Targeting of Platinum Anti-Cancer Drugs

inferredcites →https://doi.org/10.1021/cr980421nopenalex-snapshot

Structure, Recognition, and Processing of Cisplatin−DNA Adducts

inferredcites →https://doi.org/10.1021/mp4003688openalex-snapshot

LHRH-Targeted Nanogels as a Delivery System for Cisplatin to Ovarian Cancer

inferredcites →https://doi.org/10.1038/bjc.1990.236openalex-snapshot

The effects of gonadotrophin releasing hormone analogues in prostate cancer are mediated through specific tumour receptors

inferredcites →https://doi.org/10.1038/nrc1670openalex-snapshot

Breast cancer metastasis: markers and models

inferredcites →https://doi.org/10.1038/sj.bjc.6601881openalex-snapshot

HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review

inferredcites →https://doi.org/10.1038/sj.bjc.6602564openalex-snapshot

Preclinical relevance of dosing time for the therapeutic index of gemcitabine–cisplatin

inferredcites →https://doi.org/10.1038/sj.onc.1206933openalex-snapshot

Cisplatin: mode of cytotoxic action and molecular basis of resistance

inferredcites →https://doi.org/10.1039/b507716hopenalex-snapshot

Synthesis and characterisation of estrogenic carriers for cytotoxic Pt(ii) fragments: biological activity of the resulting complexes

inferredcites →https://doi.org/10.1056/nejm199003223221204openalex-snapshot

Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and Vomiting

inferredcites →https://doi.org/10.1073/pnas.0809154105openalex-snapshot

Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticles

inferredcites →https://doi.org/10.1073/pnas.94.4.1420openalex-snapshot

Recovery of pituitary function after treatment with a targeted cytotoxic analog of luteinizing hormone-releasing hormone

inferredcites →https://doi.org/10.1093/jnci/88.19.1346openalex-snapshot

DNA Repair: Enzymatic Mechanisms and Relevance to Drug Response

inferredcites →https://doi.org/10.1093/oxfordjournals.humrep.a138714openalex-snapshot

The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers

inferredcites →https://doi.org/10.1095/biolreprod.105.043471openalex-snapshot

Targeting Breast and Prostate Cancers Through Their Hormone Receptors1

inferredcites →https://doi.org/10.1111/j.1464-410x.2013.11796.xopenalex-snapshot

Luteinizing hormone‐releasing hormone ( LHRH ) receptor agonists vs antagonists: a matter of the receptors?

inferredcites →https://doi.org/10.1124/jpet.105.098855openalex-snapshot

Novel Polymeric Prodrug with Multivalent Components for Cancer Therapy

inferredcites →https://doi.org/10.1126/science.2470152openalex-snapshot

Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

inferredcites →https://doi.org/10.1126/science.277.5328.965openalex-snapshot

AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer

inferredcites →https://doi.org/10.1142/s1088424610002744openalex-snapshot

Microwave assisted solid-phase synthesis of substituted tetraazaporphyrins and a phthalocyanine-peptide conjugate

inferredcites →https://doi.org/10.1158/0008-5472.can-03-1047openalex-snapshot

EphB2 as a Therapeutic Antibody Drug Target for the Treatment of Colorectal Cancer

inferredcites →https://doi.org/10.1158/1078-0432.ccr-09-1745openalex-snapshot

Targeted Drug and Gene Delivery Systems for Lung Cancer Therapy

inferredcites →https://doi.org/10.1158/1535-7163.mct-06-0089openalex-snapshot

Carboplatin nanocapsules: a highly cytotoxic, phospholipid-based formulation of carboplatin

inferredcites →https://doi.org/10.1158/1535-7163.mct-14-0474openalex-snapshot

Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA -Mutated and BRCA –Wild-Type Triple-Negative Breast Cancer

inferredcites →https://doi.org/10.1159/000018737openalex-snapshot

Molecular Aspects of Pancreatic Cancer and Future Perspectives

inferredcites →https://doi.org/10.1186/1471-2407-14-847openalex-snapshot

Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125

inferredcites →https://doi.org/10.1186/1477-7827-11-16openalex-snapshot

Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study

inferredcites →https://doi.org/10.1358/dof.2002.027.04.666175openalex-snapshot

Cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH): A new approach to targeted chemotherapy

inferredcites →https://doi.org/10.1371/journal.pone.0143277openalex-snapshot

Bromoenol Lactone Attenuates Nicotine-Induced Breast Cancer Cell Proliferation and Migration

inferredcites →https://doi.org/10.1530/eje.0.1410001openalex-snapshot

Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors

inferredcites →https://doi.org/10.1530/eje.0.1460001openalex-snapshot

Biology of the gonadotropin-releasing hormone system in gynecological cancers

inferredcites →https://doi.org/10.1593/neo.08466openalex-snapshot

Squalene Selectively Protects Mouse Bone Marrow Progenitors Against Cisplatin and Carboplatin-Induced Cytotoxicity In Vivo Without Protecting Tumor Growth

inferredcites →https://doi.org/10.18632/oncotarget.546openalex-snapshot

Receptor-targeted therapy of human experimental urinary bladder cancers with cytotoxic LH-RH analog AN-152 (AEZS-108)

inferredcites →https://doi.org/10.2165/00003088-198510050-00002openalex-snapshot

Clinical Significance of Esterases in Man

inferredcites →https://doi.org/10.2174/092986708785908978openalex-snapshot

Carbohydrate-Metal Complexes and their Potential as Anticancer Agents

inferredcites →https://doi.org/10.2174/1381612043383971openalex-snapshot

Membrane Disrupting Lytic Peptides for Cancer Treatments

inferredcites →https://doi.org/10.2174/1381612053507594openalex-snapshot

Targeting Cytotoxic Conjugates of Somatostatin, Luteinizing Hormone- Releasing Hormone and Bombesin to Cancers Expressing Their Receptors: A “Smarter” Chemotherapy

inferredcites →https://doi.org/10.2967/jnumed.112.117796openalex-snapshot

Imaging VCAM-1 as an Indicator of Treatment Efficacy in Metastatic Ovarian Cancer

inferredcites →https://doi.org/10.3322/caac.21203openalex-snapshot

Breast cancer statistics, 2013

inferredcites →https://doi.org/10.3892/or.2011.1340openalex-snapshot

Effective targeted chemotherapy using AEZS-108 (AN-152) for LHRH receptor-positive pancreatic cancers

inferredcites →https://doi.org/10.4331/wjbc.v6.i3.231openalex-snapshot

Current medical treatment of estrogen receptor-positive breast cancer

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4137500openalex-extracted

inferred← citeshttps://doi.org/10.1002/ntls.70005openalex-snapshot

Some Biological Applications and Mechanistic Insights of Benzaldehyde‐Substituted Thiosemicarbazones and Their Metal Complexes: A Review

inferred← citeshttps://doi.org/10.1002/smll.202002044openalex-snapshot

Is GSH Chelated Pt Molecule Inactive in Anti‐Cancer Treatment? A Case Study of Pt6GS4

inferred← citeshttps://doi.org/10.1007/s11255-024-04303-2openalex-snapshot

Platinum-based chemotherapies-induced nephrotoxicity: mechanisms, potential treatments, and management

inferred← citeshttps://doi.org/10.1016/b978-0-12-801238-3.98031-0openalex-snapshot

Gonadotropin Releasing Hormone

inferred← citeshttps://doi.org/10.1016/j.apm.2024.06.002openalex-snapshot

Impact of drug dispersion on tumor-effector dynamics during combined chemo-immunotherapy with sensitivity analysis

inferred← citeshttps://doi.org/10.1016/j.cclet.2025.110961openalex-snapshot

Advanced nanosystem for target recognition and precise dual-mode imaging-guided photothermal therapy against triple-negative breast cancer

inferred← citeshttps://doi.org/10.1016/j.ejmech.2022.114679openalex-snapshot

Discovery of the thieno[2,3-d]pyrimidine-2,4-dione derivative 21a: A potent and orally bioavailable gonadotropin-releasing hormone receptor antagonist

inferred← citeshttps://doi.org/10.1016/j.molstruc.2026.146815openalex-snapshot

Experimental and quantum chemical investigation of Carboplatin-Guanine biomolecular complex: a potential chemotherapeutic agent for metastatic breast cancer

inferred← citeshttps://doi.org/10.1016/j.mtcomm.2024.109573openalex-snapshot

Electronic and geometric properties of M@Pt12 bimetallic clusters (M = Li, Na, K): A density functional theory

inferred← citeshttps://doi.org/10.1016/j.nantod.2024.102195openalex-snapshot

Ultrasmall platinum nanoclusters: A potent chemotherapeutic drug for cancer-specific DNA damage with optimizing therapeutic efficacy while minimizing systemic toxicity

inferred← citeshttps://doi.org/10.1016/j.pharmr.2025.100087openalex-snapshot

Metal-based antibody, nanobody, and peptide conjugates: Potential for breast cancer therapy

inferred← citeshttps://doi.org/10.1021/acsami.5c09286openalex-snapshot

Platinum(IV) Prodrug-Coupled TAT Nuclear-Targeting Peptide for Drug Delivery and High Antitumor Efficacy with Low Toxicity

inferred← citeshttps://doi.org/10.1021/acsomega.0c03991openalex-snapshot

Synthesis of Radiolabeled Technetium- and Rhenium-Luteinizing Hormone-Releasing Hormone (99mTc/Re-Acdien-LHRH) Conjugates for Targeted Detection of Breast Cancer Cells Overexpressing the LHRH Receptor

inferred← citeshttps://doi.org/10.1111/cbdd.14180openalex-snapshot

Peptide‐based diagnostic and therapeutic agents: Where we are and where we are heading?

inferred← citeshttps://doi.org/10.1186/s12967-024-05055-4openalex-snapshot

PLA2G4A and ACHE modulate lipid profiles via glycerophospholipid metabolism in platinum-resistant gastric cancer

inferred← citeshttps://doi.org/10.1371/journal.pone.0287151openalex-snapshot

Therapeutic dosing and targeting efficacy of Pt-Mal-LHRH towards triple negative breast cancer

inferred← citeshttps://doi.org/10.18093/0869-0189-2026-36-4-685-694openalex-snapshot

Gonadotropin-releasing hormone and the lungs

inferred← citeshttps://doi.org/10.21203/rs.3.rs-8973876/v1openalex-snapshot

EccDNA-oriented HGF potential role in platinum resistance and cancer progression based on differential abundance analysis of eccDNAs in lung cancer

inferred← citeshttps://doi.org/10.2174/0929867328666210806110857openalex-snapshot

Recent Progresses in Conjugation with Bioactive Ligands to Improve the Anticancer Activity of Platinum Compounds

inferred← citeshttps://doi.org/10.5306/wjco.v9.i8.188openalex-snapshot

Combination immunotherapy with Survivin and luteinizing hormone-releasing hormone fusion protein in murine breast cancer model

inferred← citeshttps://doi.org/10.7150/thno.69424openalex-snapshot

Platinum-based drugs for cancer therapy and anti-tumor strategies

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.